Subramanian Sankar insider trades

Open-market stock purchases and sales by Subramanian Sankar, Senior VP, Product Development at Nautilus Biotechnology, Inc, from SEC Form 4 filings since Feb 25, 2022.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +14%.

Recent trades

DateStockTradeValue
Mar 2, 2026NAUT Nautilus Biotechnology, IncBought (not open market)—

Companies traded

  • NAUT Nautilus Biotechnology, Inc: 4 buys, last Mar 2, 2026

Get free alerts when Subramanian Sankar files a new trade →